ProCE Banner Series

COVID-19 Case Challenges: Employing Outpatient Antivirals and Addressing Drug–Drug Interactions

In this live webinar, expert faculty address your questions on COVID-19 antiviral and drug–drug interaction management for nonhospitalized patients with COVID-19, including a discussion of current COVID-19 treatment recommendations, how to navigate drug–drug interaction resources, and strategies for mitigating clinically relevant drug–drug interactions.

  AMA
  | ANCC
Who Should Attend

This educational program is intended for PCPs, including physicians, nurses, and advanced practice providers, who care for nonhospitalized patients with COVID-19.

All Events

COVID-19 Case Challenges: Employing Outpatient Antivirals and Addressing Drug–Drug Interactions

Past Events

February

15

2024

1:00 PM - 1:45 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

ProCE Banner Faculty
Trinh P. Vu, PharmD, BCIDP

Clinical Pharmacy Specialist in Infectious Diseases
Department of Pharmacy
Emory University Hospital Midtown
Atlanta, Georgia

Topics

Welcome, Opening Remarks, and Baseline Assessment

Optimizing Outpatient Treatment of COVID-19

Attendee Questions Answered by Experts

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve learners’ knowledge and confidence in navigating drug–drug interactions when prescribing COVID-19 antivirals in outpatient settings. 

Target Audience
This educational program is intended for PCPs, including physicians, nurses, and advanced practice providers, who care for nonhospitalized patients with COVID-19.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Employ COVID-19 antivirals in outpatient settings according to national treatment guidelines
  • Assess potential drug–drug interactions for COVID-19 antivirals to inform therapeutic decisions in nonhospitalized patients
  • Design optimized antiviral regimens for nonhospitalized patients with COVID-19, employing tools and resources to navigate drug–drug interactions

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Pfizer Inc.